Protagonist Therapeutics, Inc. Profile Avatar - Palmy Investing

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injec…

Biotechnology
US, Newark [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of PTGX's Analysis
CIK: 1377121 CUSIP: 74366E102 ISIN: US74366E1029 LEI: - UEI: -
Secondary Listings
PTGX has no secondary listings inside our databases.